Indication

For the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.

Medicine details

Medicine name:
rezafungin acetate (Rezzayo)
SMC ID:
SMC2659
Pharmaceutical company
Napp Pharmaceuticals Ltd
BNF chapter
Infections
Submission type
Full
Publication due date:
09 September 2024
SMC meeting date:
06 August 2024
Patient group submission deadline:
07 May 2024